Suggestions
Kendal Ryter
VP Product Development at Inimmune Corp; Chairman of the Board Associate Research Faculty, University of Montana
Professional Background
Kendal Ryter is an experienced Research Scientist with an impressive and diverse history in the vaccine development industry. With a proven track record of success, Dr. Ryter has honed his expertise in various fields, including Good Laboratory Practice (GLP), Liquid Chromatography-Mass Spectrometry (LC-MS), and the intricate mechanisms of biotechnology. His career reflects a commitment to innovation and development within the pharmaceutical and biomedical sectors.
Currently, he holds a dual appointment at the University of Montana, where he continues to advance his research endeavors, while also serving as Vice President of Product Development at Inimmune Corp. This unique position enables him to merge academic knowledge with practical application in the field of immunotherapies, driving forward transformative approaches to healthcare solutions.
Dr. Ryter's previous experience includes a significant tenure at GlaxoSmithKline (GSK), where he served as an Interim Investigator and lab designer, contributing to the strategic direction and operational success of various projects. His journey began with solid academic foundations, having obtained his Doctor of Philosophy (PhD) in Organic Chemistry from Montana State University-Bozeman, supplemented with a Bachelor of Science (BS) in Chemistry from Fort Lewis College.
Education and Achievements
Kendal Ryter’s educational background is as distinguished as his professional track record. He earned his PhD in Organic Chemistry from Montana State University-Bozeman, a place well-known for fostering groundbreaking research and innovation in the sciences. The rigorous training and research he undertook during his doctoral studies provided him with an unparalleled understanding of chemical processes, paving the way for his future contributions in immunotherapy and vaccine development.
In addition to his PhD, Dr. Ryter holds a Bachelor of Science degree in Chemistry from Fort Lewis College, affirming his commitment to scientific advancement from an early stage in his academic career. Throughout his education, he was recognized for his keen analytical abilities and innovative research methodologies, which are evident in his current career achievements.
Achievements
Over the years, Dr. Ryter has accumulated a wealth of experiences and achievements that underscore his expertise in the pharmaceutical and vaccine development sectors. His skills in Good Laboratory Practice (GLP) have made him a reliable figure in ensuring that biopharmaceutical research adheres to the regulatory standards set forth by the U.S. Food and Drug Administration (FDA).
His proficiency with Liquid Chromatography-Mass Spectrometry (LC-MS) reflects his capability in applying advanced analytical techniques to medical research, ensuring that products not only meet but exceed the requirement for safety and efficacy. As a co-founder of Inimmune Corp, he has played a pivotal role in developing new and impactful immunotherapies, significantly impacting patients' lives and health outcomes.
Moreover, his previous roles at GSK and AMRI as a Research Scientist enriched his understanding and practical knowledge of the industry, allowing him to lead initiatives directed toward innovative health solutions. As a former Research Faculty at the University of Montana, Kendal Ryter has also contributed to the academic community, inspiring the next generation of scientists and researchers with a commitment to education and mentorship.
Through his impressive career, Kendal Ryter stands out not only for his technical skills and knowledge but also for his vision and ability to drive significant advancements in immunotherapy and vaccine development. He is dedicated to improving healthcare through research, mentorship, and an unwavering belief in the power of innovative science.